Barclays analyst Steve Valiquette lowered the firm’s price target on Medical Properties Trust to $10 from $12 and keeps an Overweight rating on the shares. The analyst says the company “has wandered into uncharted waters” for a real estate investment trust with potential to own a large stake in a managed care business as collateral to be “made whole” on its original hospital real estate investments with Prospect Medical. With additional uncertainty around the transaction, plus Medical Properties’ dividend cut news, the firm dropped the price target.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MPW:
- Medical Properties’ (NYSE:MPW) Financial Shake-Up: Dividend Halved, Stock Downgraded
- XPeng upgraded, Napco downgraded: Wall Street’s top analyst calls
- Medical Properties Trust cuts quarterly dividend to 15c per share
- Medical Properties Trust downgraded to Underweight from Neutral at JPMorgan
- Medical Properties Trust (NYSE:MPW) Addresses WSJ Claims, Reassures Stakeholders